Hunter Perkins Capital Management’s Globus Medical GMED Stock Holding History

Hunter Perkins Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Hold	14,244	–	–	0.25%	79
2026 Q1	$1.23M	Buy	14,244 +2,349	+20%	+$211K	0.29%	67
2025 Q4	$1.04M	Hold	11,895	–	–	0.24%	80
2025 Q3	$681K	Buy	11,895 +3,065	+35%	+$176K	0.15%	97
2025 Q2	$521K	Hold	8,830	–	–	0.12%	94
2025 Q1	$646K	Hold	8,830	–	–	0.15%	86
2024 Q4	$730K	Sell	8,830 -2,000	-18%	-$158K	0.15%	84
2024 Q3	$775K	Sell	10,830 -4,730	-30%	-$334K	0.16%	83
2024 Q2	$1.07M	Buy	15,560 +3,035	+24%	+$181K	0.22%	65
2024 Q1	$672K	Buy	+12,525	New	+$673K	0.14%	79

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Hunter Perkins Capital Management's GMED Position: Q2 2026 in Review

Hunter Perkins Capital Management held its Globus Medical (GMED) position steady in Q2 2026 at 14,244 shares worth $1.13M. The position accounts for 0.25% of the portfolio, ranked #79.

Hunter Perkins Capital Management first reported a position in GMED in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.23M in Q1 2026. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Hunter Perkins Capital Management held 14,244 shares of Globus Medical worth $1.13M as of Q2 2026.
Hunter Perkins Capital Management left its Globus Medical share count unchanged in Q2 2026.
Globus Medical made up 0.25% of Hunter Perkins Capital Management's portfolio in Q2 2026, its #79 holding.
Hunter Perkins Capital Management first reported a position in Globus Medical in Q1 2024 and has held it in 10 quarters since.
Hunter Perkins Capital Management's Globus Medical position peaked at $1.23M in Q1 2026.
596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Hunter Perkins Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.